David-Teamen / Shutterstock.com
Pharmaceutical company Millennium Pharmaceuticals has sued Actavis, accusing it of infringing a patent covering a drug used to treat myeloma and mantle cell lymphoma.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Millennium Pharmaceuticals, Actavis, patent infringement, patent, Food and Drug Administration, New Drug Application, Velcade, lymphoma, cancer,
